Blood sample for genetic analysis

GENETIC4 trials

Sponsors

University Hospital, Clermont-Ferrand, Institut de cancérologie Strasbourg Europe, Hospices Civils de Lyon, IRCCS San Raffaele

Conditions

Amyotrophic Lateral Sclerosis (ALS)Autoimmune DiseasesAutoinflammatory DiseaseBehavioral Variant Frontotemporal Dementia (bvFTD)Cortical Basal Syndrome (CBS)Genetic DiseaseHER2-positive Breast CancerNeurodegenerative Disease

Unknown Phase

The Study of the Prevalence Fibromuscular Dysplasia in Patient With Haematoma or Spontaneous Coronary Artery Dissection.

CompletedNCT02799186

University Hospital, Clermont-FerrandSpontaneous Coronary Artery Dissection, Spontaneous Coronary Artery Haematoma

Start: 2016-05-31End: 2019-11-04Target: 200Updated: 2022-01-24

Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer

RecruitingNCT04638725

Institut de cancérologie Strasbourg EuropeHER2-positive Breast Cancer

Start: 2021-12-15End: 2029-12-15Target: 9000Updated: 2022-08-03

Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases

RecruitingNCT06435468

Hospices Civils de LyonAutoimmune Diseases, Autoinflammatory Disease, Genetic Disease +1

Start: 2025-02-26End: 2035-07-27Target: 400Updated: 2025-12-22

Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases

Enrolling by invitationNCT07567664

IRCCS San RaffaeleAmyotrophic Lateral Sclerosis (ALS), Behavioral Variant Frontotemporal Dementia (bvFTD), Cortical Basal Syndrome (CBS) +3

Start: 2017-06-01End: 2027-03-01Target: 645Updated: 2026-05-05